Cogent Biosciences, Inc.

NASDAQ:COGT

Biotechnology

Healthcare
$27.74 +2.60%

+$0.88 today

Market cap
$4.83B
Beta
0.35
P/E (TTM)
-6.6
EPS (TTM)
-$5.26
52W Low $6.92High $43.73

Volume 1.68M

Average 2.15M

Balance Sheet

Inspect the capital base behind the business.

Assets

$937.61M

FY 2025 · Annual

+185.9% YoY

Liabilities

$301.24M

FY 2025 · Annual

+320.7% YoY

Equity

$636.37M

FY 2025 · Annual

+148.3% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents219.68M139.89M53.23M98.17M312.01M
Short-term Investments0119.39M212.48M188.91M588.75M
Net Receivables00000
Inventory00000
Other Current Assets01.26M5.06M9.4M9.59M
Total Current Assets222.63M264.97M270.77M296.47M910.36M
Property, Plant & Equipment (Net)4.48M31.1M30.34M26.56M23.54M
Goodwill00000
Intangible Assets00000
Long-term Investments1.26M07.46M00
Tax Assets00000
Other Non-current Assets3.73M4.75M4.86M4.86M3.72M
Total Non-current Assets9.46M35.84M42.67M31.43M27.25M
Total Assets232.09M300.81M313.44M327.9M937.61M
Account Payables3.48M5.84M10.66M12.01M9.5M
Short-term Debt00001.55M
Tax Payables00000
Deferred Revenue3.06M1.7M000
Other Current Liabilities3.62M6.47M10.32M12.63M52.9M
Total Current Liabilities17.08M26.85M38.17M55.71M63.95M
Long-term Debt0000237.25M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0000(14.32M)
Total Non-current Liabilities831K18.23M17.47M15.9M237.28M
Total Liabilities17.91M45.08M55.64M71.61M301.24M
Common Stock44K70K86K110K161K
Retained Earnings(270.97M)(411.21M)(603.62M)(859.48M)(1.19B)
Accumulated OCI(0)(104K)246K447K355K
Other Stockholders Equity00000
Minority Interest00000
Total Equity214.18M255.74M257.8M256.29M636.37M
Total Debt3.16M19.65M18.85M17.47M253.15M
Net Debt(216.53M)(120.24M)(34.38M)(80.7M)(58.86M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$181.2M
Short-term Investments$611.1M
Other Current$12.5M
Total Current Assets$804.8M
PP&E (Net)$27.4M
Other Non-current$2.4M
Total Non-current Assets$29.7M
Total Assets$834.5M

Analysis

Selected assets total $834.5M for Latest. The largest visible component is Short-term Investments at $611.1M, about 73.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026
4Statement of changes in beneficial ownershipOct 5, 2026
8-KCurrent reportSep 2, 2026
4Statement of changes in beneficial ownershipAug 31, 2026

How much cash does COGT have?

Cogent Biosciences, Inc. (COGT) reported $312.01M in cash and equivalents in fiscal 2025.

How much debt does COGT carry?

Cogent Biosciences, Inc. (COGT) reported $253.15M of total debt, with net debt of -$58.86M.